Introduction
T he overexpression of somatostatin receptors (SSTR) on a variety of human neuroendocrine tumors has led to interest in these as targets for tumor imaging and therapy. The natural ligand for these receptors, somatostatin (SST), was first described in 1973 as a hypothalamic hormone that inhibits secretion of growth hormones [1] and later on found in two physiological forms-SST-14 and SST-28 [2] . While previous studies have shown that both SST-14 and SST-28 may function as different neurotransmitters [3] and have similar binding affinities toward SSTR, the short biological half-life (2-4 min) limits their direct application for developing SSTR-targeted imaging probes [4] . As such, various SST analogs have been designed and characterized.
Among all SST analogs, octreotide and its derivatives have been widely used as imaging agents due to improved biological pharmacokinetics and targeting specificity [5, 6] . 111 In-labeled octreotide ( 111 In-OctreoScan; biological half-life, 1.7-1.9 h) was the first SSTR-targeting radiotracer approved for clinical use in the USA [7] . Since then, 68 Ga, 90 Y, and 177 Lu labeled DOTA- [Tyr 3 ]-octreotide (DOTATOC; DOTA: 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) have gained significant relevance for positron emission tomography (PET) and peptide receptor radiotherapy [8] [9] [10] .
To date, 68 Ga-DOTATOC-based PET imaging has been used successfully for diagnosis and therapeutic management of SSTR-expressing tumors [11, 12] . However, as the NOTA-Ga (III) complex (NOTA: 1,4,7-triazacyclononane-1,4,7-triacetic acid) is more thermodynamically stable compared to that of DOTA-Ga(III) complex (log K NOTA-Ga(III) 031.0 vs. log K DOTA-Ga(III) 021.3) [13] , Eisenwiener et al. have designed and synthesized a NOTA-based scaffold to conjugate targeting molecules for 68 Ga-labeling [14] . Recently, Garcia Garayoa et al. proposed that the presence of negative charges may lead to new peptide analogs with improved biodistribution profiles [15] . This hypothesis was initially based on observations from antibodies since electrostatic effects, particularly in radiolabeled human polyclonal antibodies carrying negative charges, influence the biodistribution profile [16] and can reduce hepatic retention [17] . Although the studies performed by Anderson et al. [18] and Garcia Garayoa et al. [15] yielded similar results on peptide conjugates, their findings were generated by using molecules with different chelating systems and varying hydrophilicities. As such, it is of importance to further define the impact of the molecular charge on the overall performance of peptide conjugates.
In this study, we have synthesized a series of [Tyr 3 ] octreotide conjugates ( Fig. 1 ) and aimed to evaluate the physiological influence of the molecular charge by modifying chelators of the peptide conjugates. As the carboxylates on the NOTA-based scaffolds of the [Tyr 3 ]octreotide conjugates were in the form of conjugate base (R-COO-) during our biological evaluations, we therefore hypothesized that the addition of varying numbers of carboxylate groups on the NOTA-based scaffolds would increase the overall negative charge of the molecules without significantly changing hydrophilicity. The conjugates were investigated for binding to AR42J rat pancreatic cancer cells, and the 68 Ga-labeled conjugates were evaluated for internalization into these cells. The tumor localization and tissue accumulation of the 68 Ga-labeled conjugates were also analyzed in mice bearing AR42J xenografts. 68 Ga-1 illustrated improved tumor to background ratios than the other conjugates or 68 Ga-DOTATOC.
Materials and Methods

General
The NOTA-based scaffolds were synthesized based on previously published procedures [19, 20] . All reagents and solvents were purchased from Sigma-Aldrich (St. Louis, MO) and used as received unless otherwise noted. Milli-Q water (18 MΩ-cm) was obtained from a Millipore Gradient Milli-Q water system (Billerica, MA). Low adhesion 1.5 ml vials and C 18 Sep-Pak cartridges were purchased from USA Scientific (Ocala, FL) and Millipore (Billerica, MA), respectively. C 18 Sep-Pak cartridges were conditioned with ethanol and water (5 ml of each) before use. Nitric acid (10-20 %) used for acid washing was prepared by diluting 70 % nitric acid with Milli-Q water. 68 Ga was eluted from IGG100 (Eckert & Ziegler Isotope Products, Berlin, Germany) using 0.1 M HCl. Strata X-C columns were purchased from Phenomenex (Torrance, CA ]octreotide conjugation with the NOTA-based scaffolds was achieved by reacting the peptide through a primary amine in the N-terminal D-Phe. The carboxylates glutaric acid 1-tert-butyl ester on the NOTA-based scaffolds (3.3-4.1 mg, 6.0 μmol) were activated by 2-(1H-7-azabenzotriazol-1-yl)-1,1,3,3-tetramethyl uronium hexafluorophosphate (2.3 mg, 6.0 μmol) and then reacted with the peptide (2.3 mg, 2.0 μmol; molar ratio scaffold: peptides03:1) overnight at room temperature in DMSO. The unreacted scaffolds and peptides were removed by HPLC with a Vydac C 18 column (5 μm, 4.6×250 mm), followed by lyophilization. After deprotecting with 95 % TFA, the crude [Tyr 3 ]octreotide conjugates were purified again by HPLC (for both HPLC purifications, the flow rate was set at 1 ml/min using a gradient system starting from 100 % solvent A by a linear ramp to 100 % solvent B at 50 min. Solvent A, 0.1 % trifluoroacetic acid (TFA) in water (v/v); solvent B, 0.1 % TFA in acetonitrile (v/v) 
Radiochemistry
The 68 Ga eluate was purified by a Strata X-C column following the published method [21] . The Strata X-C column contained 30 mg of the cation resin and eliminates the impurities of the 68 Ga eluate [21] . The Strata X-C columns were used without preconditioning. The eluate (6-10 ml) was slowly passed through the column (2 ml/ min) and the resin was dried with air. The purified 68 Ga eluate was obtained by desorbing the activity from the resin with 0.5 ml of 0.02 M HCl/98 % acetone.
For radiolabeling, the purified 68 Ga eluate (50 μl, 1.0-1.5 mCi) was added to a 1.5 ml vial containing 1-10 μg of the [Tyr 3 ] octreotide conjugate in 50 μl of 1 M 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES, pH 4). The reaction mixture was incubated at 95°C for 10 min in an Eppendorf thermomixer at a constant shaking rate of 1,000 rpm. After addition of diethylenetriamine pentaacetic acid (DTPA, 5 mM, 20 μl) to challenge the nonspecifically bound 68 Ga, the labeled peptide was purified by a pre-conditioned C 18 Sep-Pak cartridge as previously described [21] . HPLC analysis was performed to determine the radiochemical purity of each 68 Ga-labeled peptide conjugate.
Determination of Log P Values
The 68 Ga-labeled [Tyr 3 ]octreotide conjugates (20 μl with 5-10 μCi per conjugate) were added into an equal volume mixture of noctanol and Milli-Q water (500 μl/ea). The samples were vortexed at 1,000 rpm for 1 h, followed by removing aliquots of 100 μl from M. Lin et al.: 68 both the aqueous water and the organic n-octanol layers and counted separately in a γ counter (Wallac Wizard 3" Automatic Gamma Counter, PerkinElmer, Waltham, MA). The partition coefficients defined as (activity concentration in n-octanol)/(activity concentration in aqueous layer) were then calculated to yield log P values.
Cell Culture
The AR42J rat pancreatic cancer cell line was purchased from ATCC (Manassas, VA). The cells were maintained in IMDM (Iscove's Modified Dulbecco's Media) medium with 20 % fetal bovine serum and 0.1 % gentamicin at 37°C in an atmosphere containing 5 % CO 2 .
Internalization Studies
Twenty-four hours prior to the assay, AR42J cells were seeded in six-well plates (1×10 6 cells/well) and allowed to adhere. The cells were rinsed with 10 mM phosphate buffered saline (PBS), followed by addition of the 68 Ga-labeled conjugates (∼0.7 nM/well; 1 ml/ well) in Dulbecco's modified eagle medium (DMEM; containing 0.1 % of bovine serum albumin). Next, the cells were incubated at 37°C for 10, 30, 60, and 120 min to allow for binding and internalization. After incubation, the cells were washed twice with cold PBS. Surface-bound activity was removed by acid wash (50 mM glycine/HCL, 100 mM NaCl, pH 2.8, 2×1 ml for 5 min at room temperature). Finally, the cells were lysed with 1 N NaOH (2×1 ml). Surface-bound and internalized activities were measured in a γ-counter. The protein concentration was determined using Bio-Rad Protein Assay Kit (Hercules, CA) and results were calculated as percentage of total added radioactivity per 0.1 mg of protein.
Receptor Binding Assays
Somatostatin receptor binding affinities of [Tyr 3 ]octreotide and the five peptide conjugates were determined by competitive binding assays with 68 Ga-DOTATOC as a radioligand. Experiments were performed on 24-well plates seeded with AR42J rat pancreatic tumor cells (5×10 5 cells/well). The cells were rinsed with 10 mM PBS, followed by the addition of 68 Ga-DOTATOC solutions (∼3.3 × 10 −2 nM/well; 0.5 ml/well) mixed with the peptide conjugates at 0-1,000 nM in DMEM (containing 0.1 % of bovine serum albumin). After incubation at 37°C for 1 h, the cells were rinsed twice with cold PBS and lysed with 1 N NaOH. The cell lysate was collected and counted by a γ-counter. The cell uptake of 68 Ga-DOTATOC was normalized in terms of added radioactivity and protein concentration of the seeded cells. The IC 50 values were calculated by fitting the quadruplicate data with nonlinear regression using Graph-Pad Prism (GraphPad Software, La Jolla, CA).
Immunofluorescence Microscopy
In vitro fluorescent imaging studies were performed according to a published procedure [22] with slight modifications. Forty-eight hours prior to the studies, AR42J cells were grown on four-well 
Biodistribution
All animal studies were performed in compliance with guidelines set forth by the National Institutes of Health Office of Laboratory Animal Welfare and approved by the Washington University Animal Studies Committee. The animal model was established by subcutaneous injection of AR42J cell suspension (5×10 6 cells) into the right flank of male athymic nude mice. When the xenografts reached the size of 50-200 mm 3 (typically 2-3 weeks post subcutaneous injection), the tumor-bearing mice were randomly grouped for the biodistribution studies. During the studies, each mouse was weighed and received 5 μCi of a 68 Ga-labeled peptide conjugate via tail vein injection. The mice were anesthetized and sacrificed at 30 min, 1 h, and 2 h p.i. (n04). Blood, lung, liver, spleen, kidney, muscle, fat, heart, pancreas, stomach, and tumor were collected, weighed, and counted by a γ-counter. The percentage of injected dose per gram (%ID/g) for each sample and the standard deviation (SD) for each group of the organ were determined by comparing the standards (n03) prepared along with the injection doses.
Statistical Analysis
Quantitative data were processed by Prism 5 (GraphPad Software, La Jolla, CA) and expressed as mean ± SD. All analyses were performed by one-way analysis of variance and Student's t test. P values G0.05 were considered statistically significant.
Results
Radiochemistry
The 68 Ga labeling efficiencies were evaluated at 95°C for all conjugates by varying the concentrations of the conjugates. At the non-carrier-added level, 1 μg of all peptide conjugates in 50 μl of 1 M HEPES (pH 4) were successfully labeled with 68 Ga with high labeling efficiencies (980 %). The 68 Ga-labeled conjugates were purified in one step using a pre-activated C 18 Sep-Pak light cartridge with a 975 % recovery rate. The radiochemical purity of the labeled peptide conjugates post purification by C 18 Sep-Pak cartridge was 995 % as determined by HPLC. The overall radiochemical procedure took 20 min with resulting specific activities of ∼48 GBq/μmol (1.3 Ci/ μmol).
Determination of Log P Values
As shown in Table 1 , all of the 68 Ga-labeled peptide conjugates have similar hydrophilic characteristics with log P values less than −2.3. This indicates the incorporation of additional carboxylate groups or negative charges did not result in a clear increase or decrease of hydrophilicity for the peptide conjugates.
Internalization Studies
Rapid internalization of 68 Ga-DOTATOC as the reference peptide conjugate was observed throughout the studies (Fig. 2) . Internalization of 68 Ga-1 (three carboxylates) was slightly higher than that of the reference peptide at all timepoints. However, internalization of 68 Ga-NO2ATOC (two carboxylates) and 68 Ga-2 (four carboxylates) was significantly decreased and that of 68 Ga-3 (five carboxylates) was negligible. These results suggest that the chelator with the same core but various number of carboxylate groups has a significant impact on the internalization.
Receptor Binding Assays
The in vitro SSTR binding affinities of the [Tyr 3 ]octreotide and its conjugates were determined by a competitive cell binding assays using 68 Ga-DOTATOC as the SSTR-specific radioligand. In this study, the binding affinity was tested for the unlabeled conjugates. 3 ]octreotide conjugates. In addition, our findings also suggest that the increased number of carboxylates on the chelator of the same core can result in a reduced binding affinity.
Immunofluorescence Microscopy
Previous reports indicate that AR42J cells express SSTR1, 2, and 3 [22] . As octreotide analogs usually show higher binding affinities toward SSTR2 [20] , we chose this receptor as the model biomarker and determined the effect of chelator modifications in the [Tyr 3 ]octreotide conjugates on SSTR2 endocytosis. The results in Fig. 3 demonstrate that all conjugates induced receptor endocytosis in AR42J cells with DOTATOC triggering much higher SSTR2 internalization than the other conjugates.
Biodistribution
The tissue distribution profiles of 68 Ga-DOTATOC, 68 Ga-NO2ATOC, 68 Ga-1, 68 Ga-2, and 68 Ga-3 in male athymic nude mice bearing SSTR-positive AR42J tumors are summarized in Fig. 4 . Among the organs evaluated, the kidney showed the highest uptake at 30 13 .78±2.22 %ID/g), indicating that all the peptide conjugates were primarily excreted from the renal system. At 2 h p.i., while less than 52 % of the initial kidney uptake was retained for 68 Ga-NO2ATOC (7.40± 1.09 %ID/g), 68 Ga-1 (9.79±1.90 %ID/g), 68 Ga Ga-3 at 2 h p.i. was on the order of 68 Ga-1 (55 %)9 68 Ga-2 (24 %)9 68 Ga-3 (19 %). The tumor/lung, tumor/liver, tumor/kidney, tumor/pancreas, and tumor/stomach ratios for the peptide conjugates at 1 h p.i. are shown in Fig. 5 . Although 68 Ga-3 generally had lower normal tissue uptake than the other peptide conjugates, the tumor uptake was also lower and thus tumor/ normal tissue ratios are similar to 68 Ga-DOTATOC and 68 Ga-NO2ATOC. An exception to this is the tumor/stomach ratios. 68 Ga-3 had a significantly higher (PG0.01) tumor/ stomach ratio at 1 h p.i. than that of 68 Ga-DOTATOC, 68 Ga-NO2ATOC, and 68 Ga-2. Both 68 Ga-DOTATOC and 68 Ga-1 had significantly higher (PG0.05) tumor/liver and tumor/ kidney ratios than those of 68 Ga-2 and 68 Ga-3 at 1 h. In general, 68 Ga-1 was somewhat superior overall in terms of the liver, kidney, and stomach ratios.
Discussion
Due to the potential for the detection and therapy of SSTRexpressing tumors, a variety of octreotide analogs have been labeled with different radionuclides for the past decade. However, interest in using 68 Ga-labeled octreotide analogs for clinical PET applications dramatically increased after Henze et al. reported the promising imaging results of 68 Ga-DOTATOC in patients with SSTR-overexpressed meningiomas [23] . As the availability of 68 Ga from a 68 Ge/ 68 Ga generator eliminates the need of an onsite cyclotron, and fully automated systems for synthesizing 68 Ga-labeled peptides have become commercially available [21] , 68 Ga-labeled octreotide analogs have recently gained significant attention for their potential in diagnosing and managing neuroendocrine tumors [24] [25] [26] [27] .
Our work aimed to evaluate the physiological influence of chelator modifications on the peptide imaging agents in vitro and in vivo. In order to investigate this, we have used [Tyr 3 ]octreotide as a model peptide system and conjugated this structure with the NOTA-based scaffolds having two to five copies of carboxylate groups. All peptide conjugates studied herein had similar partition coefficients and hydrophilicities. As the chemical structures of the pendent arms on the NOTA-based scaffolds are similar to those of acetic acid or succinic acid, their logarithmic acid dissociation constant [28] is well below 6 [29] . Considering all of our biological evaluations were performed in the cultured cells and laboratory mice, the carboxylates of the NOTA-based Fig. 4 . Biodistribution profiles of 68 Ga-DOTATOC, 68 Ga-NO2ATOC, 68 Ga-1, 68 Ga-2, 68 Ga-3 in AR42J tumor bearing athymic nude mice at 30 min and 1 and 2 h p.i. Data are presented as %ID/g±SD (n04). M. Lin et al.: 68 scaffolds are believed to be persisted as the conjugate base (R-COO-) (the pH value of the blood in the laboratory mouse is 7.3-7.4 [30] ). In this regard, our studies allowed us for a more precise evaluation of the effects of molecular charge on the [Tyr 3 ]octreotide conjugates. In vitro internalization studies in the AR42J rat pancreatic cancer cells reflected an agonistic behavior for the all peptide conjugates. This finding was consistent with the data previously reported for the other octreotide analog conjugates labeled by different radionuclides [14, 31, 32] . The internalization of the 68 Ga-labeled conjugate 1 (three carboxylates) was comparable to that of 68 Ga-DOTATOC (three carboxylates) although some discrepancy appears when comparing the radioactive internalization studies with the microscopy. The reason for this is not clear although it may be that the DOTATOC is washed out in the radiotracer internalization studies whereas the confocal images are showing the receptor itself (which remains inside the cell), rather than the compound. This is supported by the biodistribution data. This may also be partially due to effects of other somatostatin receptors in the radioactive internalization studies, whereas the confocal images only show SSTR2. However, the internalization of 68 Ga-labeled NO2ATOC (two carboxylates) and the conjugates 2 (four carboxylates) and 3 (five carboxylates) was significantly reduced. Considering the major compositions (e.g. phospholipids, glycoproteins) that lead to cell membranes with negative charges, it is somewhat surprising that 68 Ga-NO2ATOC had poor cellular internalization. As the coordination number of Ga(III) can be either 4 or 6 [13] and Ga (III)-NO2ATOC is the only peptide conjugate with the possible coordination number of 4, this phenomenon might be explained by different coordinating systems that lead to the altered properties. Indeed, the stimulation of SSTR2 internalization by NO2ATOC was significantly lower than that of DOTATOC. Furthermore, we found that the increased number of carboxylates on the chelator of the same core seems to further reduce SSTR2 internalization and overall SSTR binding affinities. With these regards, we believe that the coordinating and chelating systems have a strong influence on the cellular internalization of the 68 Galabeled [Tyr 3 ]octreotide conjugates. Our biodistribution study shows that 68 Ga-1 has the highest tumor uptake at 1 h p.i. compared to the other peptide conjugates. Unlike the biodistribution data of 68 Ga-labeled DOTATOC and NO2ATOC, this peptide conjugate showed some washout from the tumor but still maintained the same or higher tumor accumulation at later timepoints. This washout has also been noticed by Eisenwiener et al. during biodistribution studies of 67 Ga-labeled NODAGATOC ( 67 Ga-1; the half-life of 67 Ga is 3.26 days) and DOTATOC on AR42J tumor-bearing mice [20] . Of the normal tissues, our [Tyr 3 ]octreotide conjugates predominately accumulated in the kidney. In addition to the fact that these peptide conjugates were primarily excreted from the renal system, they might be below the renal filtration limit and reabsorbed in the proximal tubular cells [33, 34] . In fact, Vegt et al. were able to reduce the kidney uptake of 111 In-labeled DTPA-octreotide by co-injecting albumin fragments or albumin-derived peptides [35, 36] . The kidney washout of 68 Ga-1, 68 Ga-2, and 68 Ga-3 was significantly altered with the number of carboxylates on the NOTA-based chelators. However, the kidney uptake of 68 Ga-DOTATOC (three carboxylates) and 68 Ga-NO2ATOC (two carboxylates) was significantly lower than that of 68 Ga-1 and 68 Ga-2 at 30 min and 1 h p.i. Thus, the number of carboxylates in the chelator of peptide conjugates and the selection of radiometal chelating systems may lead to altered biodistribution profiles. Also of interest is the increased liver signal obtained with 68 Ga-DOTATOC at 2 h. p.i. Although further investigations are needed, lower stability of the DOTA-Ga(III) complex (log K NOTA-Ga(III) 031.0 vs. log K DOTA-Ga(III) 021.3)
[13] could be one of the possible causes for this observation.
Conclusion
In this study, we evaluated four 68 Ga-labeled [Tyr 3 ] octreotide conjugates that consisted of different NOTAbased chelators with two to five copies of carboxylates and compared our results with 68 Ga-DOTATOC. Among all of the peptide conjugates, 68 Ga-1 showed a preferable biodistribution profile that was comparable to or better than that of 68 Ga-DOTATOC, while the addition of further carboxylate groups led to unfavorable biodistribution profiles. Our findings suggest that the chelator modifications and the selection of radiometal chelating systems can lead to altered pharmacokinetics.
